788 related articles for article (PubMed ID: 18436564)
21. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
[TBL] [Abstract][Full Text] [Related]
22. Effect of omega 3 and omega 6 fatty acid intakes from diet and supplements on plasma fatty acid levels in the first 3 years of life.
Hoyos C; Almqvist C; Garden F; Xuan W; Oddy WH; Marks GB; Webb KL
Asia Pac J Clin Nutr; 2008; 17(4):552-7. PubMed ID: 19114389
[TBL] [Abstract][Full Text] [Related]
23. Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention.
Baldassarre D; Amato M; Eligini S; Barbieri SS; Mussoni L; Frigerio B; Kozàkovà M; Tremoli E; Sirtori CR; Colli S
Ann Med; 2006; 38(5):367-75. PubMed ID: 16938806
[TBL] [Abstract][Full Text] [Related]
24. Consumption of n-3 polyunsaturated fatty acid-enriched eggs and changes in plasma lipids of human subjects.
Jiang Z; Sim JS
Nutrition; 1993; 9(6):513-8. PubMed ID: 7906572
[TBL] [Abstract][Full Text] [Related]
25. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
26. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[TBL] [Abstract][Full Text] [Related]
27. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.
Paulo MC; Andrade AM; Andrade ML; Morais MG; Kiely M; Parra D; Martinéz JA; Thorsdottir I; Bandarra NM
Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):664-70. PubMed ID: 18420395
[TBL] [Abstract][Full Text] [Related]
28. Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients.
Kirkegaard E; Svensson M; Strandhave C; Schmidt EB; Jørgensen KA; Christensen JH
Br J Nutr; 2012 Mar; 107(6):903-9. PubMed ID: 21791142
[TBL] [Abstract][Full Text] [Related]
29. Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study.
Christensen JH; Aarøe J; Knudsen N; Dideriksen K; Kornerup HJ; Dyerberg J; Schmidt EB
Clin Nephrol; 1998 Feb; 49(2):102-6. PubMed ID: 9524780
[TBL] [Abstract][Full Text] [Related]
30. Lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men.
Isherwood C; Wong M; Jones WS; Davies IG; Griffin BA
Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):52-8. PubMed ID: 20196970
[TBL] [Abstract][Full Text] [Related]
31. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
[TBL] [Abstract][Full Text] [Related]
32. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
[TBL] [Abstract][Full Text] [Related]
33. The Effect of n-3 Fatty Acids on Small Dense Low-Density Lipoproteins in Patients With End-Stage Renal Disease: A Randomized Placebo-Controlled Intervention Study.
Sørensen GV; Svensson M; Strandhave C; Schmidt EB; Jørgensen KA; Christensen JH
J Ren Nutr; 2015 Jul; 25(4):376-80. PubMed ID: 25771840
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
[TBL] [Abstract][Full Text] [Related]
35. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
36. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
37. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK; Abbey M; Nestel PJ; Howe PR
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[TBL] [Abstract][Full Text] [Related]
38. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
39. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors.
Murphy KJ; Meyer BJ; Mori TA; Burke V; Mansour J; Patch CS; Tapsell LC; Noakes M; Clifton PA; Barden A; Puddey IB; Beilin LJ; Howe PR
Br J Nutr; 2007 Apr; 97(4):749-57. PubMed ID: 17349088
[TBL] [Abstract][Full Text] [Related]
40. n -- 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids.
Barden AE; Dunstan JA; Beilin LJ; Prescott SL; Mori TA
Clin Sci (Lond); 2006 Oct; 111(4):289-94. PubMed ID: 16822237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
